| Date |
Title |
Category |
|
| 30/01/2009 | Zimmer reveals 4 per cent sales loss | Medical Company Financials | Read More |
| 30/01/2009 | Sara Lee reveals quarterly dividend | Pharmacy Supplier News | Read More |
| 30/01/2009 | Actelion's Zavesca receives EU approval | Pharmaceutical Company Product News | Read More |
| 30/01/2009 | Lilly sales increase 9 per cent | Pharmaceutical Company Financials | Read More |
| 30/01/2009 | Roche plans to acquire all Genentech shares | Pharmaceutical Company Financials | Read More |
| 30/01/2009 | Daiichi Sankyo attributes loss to Ranbaxy investment | Pharmaceutical Company Financials | Read More |
| 30/01/2009 | Merck in talks to purchase companies | Pharmaceutical Company Financials | Read More |
| 30/01/2009 | AstraZeneca sales rise 3 per cent | Pharmaceutical Company Financials | Read More |
| 30/01/2009 | DoH announces mixed sex penalties | Medical Government/ NHS related news | Read More |
| 30/01/2009 | Kids who watch too much TV 'grow into junk food adults' | Industry related health news | Read More |
| 30/01/2009 | Procter and Gamble reports 61 per cent increase in diluted EPS | Pharmacy Supplier News | Read More |
| 30/01/2009 | Agilent Technologies introduces new validation software | Scientific | Read More |
| 30/01/2009 | 3M reveals record annual sales | Scientific | Read More |
| 29/01/2009 | Caution against drug relapse threat | Industry related health news | Read More |
| 29/01/2009 | GlaxoSmithKline warns of legal charge | Pharmacy Supplier News | Read More |
| 29/01/2009 | Agilent Technologies to offer new data analysis software with The MathsWorks | Scientific | Read More |
| 29/01/2009 | Colgate reveals 7 per cent net income increase | Pharmacy Supplier News | Read More |
| 29/01/2009 | Report: Life expectancy is higher than ever | Medical Government/ NHS related news | Read More |
| 29/01/2009 | Roche products to be supplied to UK government | Pharmacy Supplier News | Read More |
| 29/01/2009 | Novartis' net sales rise 9 per cent | Pharmaceutical Company Financials | Read More |
